Reactions of Arsenoplatin-1 with Protein Targets: A Combined Experimental and Theoretical Study

[Image: see text] Arsenoplatin-1 (AP-1) is a dual-action anticancer metallodrug with a promising pharmacological profile that features the simultaneous presence of a cisplatin-like center and an arsenite center. We investigated its interactions with proteins through a joint experimental and theoreti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolbatov, Iogann, Cirri, Damiano, Tarchi, Matteo, Marzo, Tiziano, Coletti, Cecilia, Marrone, Alessandro, Messori, Luigi, Re, Nazzareno, Massai, Lara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864615/
https://www.ncbi.nlm.nih.gov/pubmed/35137586
http://dx.doi.org/10.1021/acs.inorgchem.1c03732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864615/
https://www.ncbi.nlm.nih.gov/pubmed/35137586
http://dx.doi.org/10.1021/acs.inorgchem.1c03732

Ejemplares similares